Politician(s) lobbied:Simon Harris (An Taoiseach), Department of the Taoiseach
Intent: To brief the Taoiseach on the pharmaceutical industry’s views and recommendations relating to matters of the Council of the European Union’s meetings on Employment, social policy, health and consumer affairs (EPSCO) and Competitiveness (COMPET).
Methods:Letter
Details by Method
Method not specified
Letter to incoming Taoiseach
Method not specified
congratulating him on his appointment
Method not specified
seeking his support regarding EPSCO and COMPET Council meetings
Method not specified
and extending an invitation to visit Ipsen facilities.
Politician(s) lobbied:Barry Andrews (MEP), European Parliament; Frances Fitzgerald (MEP), European Parliament
Intent: To brief the MEPs on the Pharmaceutical Industry’s views and recommendations for the EU pharmaceutical Strategy and urge Ireland to position itself in this European policy development as an innovator country, to ensure that any opening of intellectual rights for medicines takes great care to achieve the objective of stimulating new solutions for unmet medical needs and to protect existing innovation. To discuss the European Action Plan on Rare Diseases.
Methods:Meeting
Details by Method
Method not specified
Separate meetings between Frances Fitzgerald
Method not specified
MEP and Barry Andrews MEP and Senior Executives of Ipsen took place in Brussels on 29th of June. Ipsen took the opportunity to discuss the EU pharmaceutical strategy and EU policy for the management and treatment of rare diseases